Senior health officials in the Trump administration spent days preparing for a cautious update on autism research. Their goal was to share new federal guidance suggesting a possible link between acetaminophen use during pregnancy and higher rates of autism. The plan included highlighting a $50 million investment in research and outlining potential treatments under development.
Trump’s unexpected remarks
When the moment came, however, President Donald Trump dramatically shifted the message. Declaring the announcement a personal milestone, Trump made sweeping statements about autism’s causes, questioning the safety of Tylenol and reviving long-disputed claims about vaccines. “I’ve been waiting for this meeting for 20 years,” he said, while urging pregnant women to avoid acetaminophen and expressing doubts about immunizations.
These remarks startled officials who had anticipated a measured presentation. Instead of underscoring “possible associations” backed by research, Trump characterized Tylenol as harmful and reiterated stories about vaccines and autism—claims repeatedly debunked by scientific studies.
Reaction from the medical community
Experts and autism researchers quickly voiced concern. They warned that the president’s comments risked misinforming families and could make it harder for doctors to provide evidence-based guidance to expectant mothers. “To tell women that the one option they had available to them shouldn’t be available to them could be very problematic,” said Joshua Anbar, a professor at Arizona State University with expertise in maternal and child health.
Ashish Jha, dean of Brown University’s School of Public Health, was blunt in his assessment: “That was possibly the worst public health press conference I have ever seen in my life.”
Administration response
In the wake of the event, White House press secretary Karoline Leavitt defended the announcement, saying the administration aimed to reduce reliance on medications and encourage healthier practices. “There is mounting evidence finding a connection between acetaminophen use during pregnancy and autism,” she said, framing the move as a bold step toward protecting children’s health.
Trump’s longstanding views
Trump’s interest in autism is not new. Since the early 2000s, he has speculated about potential causes, including vaccines. His skepticism grew from personal anecdotes involving friends and his own parenting experiences. Over the years, he has raised concerns publicly, hosted autism-related fundraisers, and expressed theories about vaccination schedules.
Although advisers during his first term discouraged him from pushing these ideas, his return to office—and his appointment of Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic—has allowed him to revisit them more openly. Kennedy has pledged a wide-ranging initiative to investigate rising autism rates, even though most scientists emphasize that autism is influenced by multiple genetic and environmental factors, not a single cause.
Looking ahead
Health and Human Services officials had planned to fund the first phase of autism research by September, framing acetaminophen as a potential area of inquiry rather than a definitive answer. Their statement after the press conference underscored the uncertainty, noting that some studies show no connection between Tylenol and autism, and that acetaminophen remains one of the safest available options for pain and fever during pregnancy.
While the administration insists it will continue pursuing research into autism’s causes, Trump’s comments underscored how political messaging can clash with scientific nuance—leaving families and health professionals searching for clarity.
Bottom line for parents
Medical experts stress that pregnant women should consult their doctors before making changes to medication use. At present, there is no clear evidence that Tylenol causes autism, and vaccines remain a proven, critical safeguard for children’s health.
Related topics
Online Doctor Debunks Trump’s Acetaminophen Autism Claims
Trump Officials Reportedly Weigh Autism Medication Claims Linked to Tylenol
